Chinese Journal of Antituberculosis ›› 2021, Vol. 43 ›› Issue (6): 596-601.doi: 10.3969/j.issn.1000-6621.2021.06.013
• Original Articles • Previous Articles Next Articles
LUO Dan*, QIN Hui-fang, YE Jing, ZHAO Jin-ming, QIN Yi-xiang, LAN Ru-shu()
Received:
2021-03-04
Online:
2021-06-10
Published:
2021-06-02
Contact:
LAN Ru-shu
E-mail:gxlrshu@163.com
LUO Dan, QIN Hui-fang, YE Jing, ZHAO Jin-ming, QIN Yi-xiang, LAN Ru-shu. Analysis on gene mutation characteristics of drug resistant Mycobacterium tuberculosis and its correlation with genotypes in Guangxi[J]. Chinese Journal of Antituberculosis, 2021, 43(6): 596-601. doi: 10.3969/j.issn.1000-6621.2021.06.013
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2021.06.013
药品 | 耐药基因 | 突变菌株数 | 突变率(%) |
---|---|---|---|
异烟肼 | ahpC | 7 | 0.97 |
fabG1 | 11 | 1.53 | |
katG | 114 | 15.81 | |
kasA | 4 | 0.55 | |
inhA+fabG1 | 3 | 0.42 | |
kasA+fabG1 | 1 | 0.14 | |
katG+fabG1 | 2 | 0.28 | |
利福平 | rpoB | 88 | 12.21 |
乙胺丁醇 | embA | 2 | 0.28 |
embB | 31 | 4.30 | |
embC | 1 | 0.14 | |
embB+embA | 4 | 0.55 | |
embB+embB | 8 | 1.11 | |
embC+embB | 18 | 2.50 | |
吡嗪酰胺 | pnaD | 1 | 0.14 |
pncA | 26 | 3.61 | |
链霉素 | rpsL | 41 | 5.69 |
rrs | 31 | 4.30 | |
rpsL+rrs | 3 | 0.42 |
[1] |
王前, 李涛, 杜昕, 等. 2015—2019年全国肺结核报告发病情况分析. 中国防痨杂志, 2021,43(2):107-112. doi: 10.3969/j.issn.1000-6621.2021.02.002.
doi: 10.3969/j.issn.1000-6621.2021.02.002 |
[2] |
Luo D, Zhao J, Lin M, et al. Drug resistance in newly presenting and previously treated tuberculosis patients in Guangxi Province, PR China. Asia Pac J Public Health, 2017,29(4):296-303. doi: 10.1177/1010539517700474.
doi: 10.1177/1010539517700474 URL |
[3] | 赵雁林, 逄宇. 结核病实验室检验规程. 北京: 人民卫生出版社, 2015: 32. |
[4] |
De Almeida IN, Da Silva Carvalho W,Rossetti ML,et al.Evaluation of six different DNA extraction methods for detection of Mycobacterium tuberculosis by means of PCR-IS6110: preliminary study. BMC Res Notes, 2013,6:561. doi: 10.1186/1756-0500-6-561.
doi: 10.1186/1756-0500-6-561 URL |
[5] |
洪创跃, 杨婷婷, 李金莉, 等. 深圳市耐多药结核分枝杆菌耐药基因突变特征分析. 中国防痨杂志, 2020,42(6):583-589. doi: 10.3969/j.issn.1000-6621.2020.06.009.
doi: 10.3969/j.issn.1000-6621.2020.06.009 |
[6] |
Walker TM, Kohl TA, Omar SV, et al. Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study. Lancet Infect Dis, 2015,15(10):1193-1202. doi: 10.1016/S1473-3099(15)00062-6.
doi: 10.1016/S1473-3099(15)00062-6 URL |
[7] |
Liu Q, Luo T, Dong X, et al. Genetic features of Mycobacterium tuberculosis modern Beijing sublineage. Emerg Microbes Infect, 2016,5(4):e14. doi: 10.1038/emi.2016.14.
doi: 10.1038/emi.2016.14 |
[8] |
Sun H, Zhang C, Xiang L, et al. Characterization of mutations in streptomycin-resistant Mycobacterium tuberculosis isolates in Sichuan,China and theassociation between Beijing-lineage and dual-mutation in gidB. Tuberculosis (Edinb), 2016,96:102-106. doi: 10.1016/j.tube.2015.09.004.
doi: 10.1016/j.tube.2015.09.004 URL |
[9] |
Martínez LM, Castro GP, Guerrero MI. A molecular platform for the diagnosis of multidrug-resistant and pre-extensively drug-resistant tuberculosis based on single nucleotide polymorphism mutations present in Colombian isolates of Mycobacterium. Mem Inst Oswaldo Cruz, 2016,111(2):93-100. doi: 10.1590/0074-02760150306.
doi: 10.1590/0074-02760150306 URL |
[10] |
Ali A, Hasan Z, McNerney R,et al.Whole genome sequencing based characterization of extensively drug-resistant mycobacterium tuberculosis isolates from Pakistan. PLoS One, 2015,10(2):e0117771. doi: 10.1371/journal.pone.0117771.
doi: 10.1371/journal.pone.0117771 URL |
[11] |
董苏荣, 徐娟, 徐祖龙. 泰州地区结核分枝杆菌一线抗结核药耐药基因检测结果分析. 微生物与感染, 2017,17(6):60-62.doi: 10.3969/j.issn.1671-0142.2017.06.019.
doi: 10.3969/j.issn.1671-0142.2017.06.019 |
[12] |
Ocheretina O, Escuyer VE, Mabou MM, et al. Correlation between genotypic and phenotypic testing for resistance to rifampin in Mycobacterium tuberculosis clinical isolates in Haiti: investigation of cases with discrepant susceptibility results. PLoS One, 2014,9(3):e90569. doi: 10.1371/journal.pone.0090569.
doi: 10.1371/journal.pone.0090569 URL |
[13] |
Thirumurugan R, Kathirvel M, Vallayyachari K, et al. Molecular analysis of rpoB gene mutations in rifampicin resistant Mycobacterium tuberculosis isolates by multiple allele specific polymerase chain reaction in Puducherry, South India. N Engl J Med, 2013,369(3):290-292. doi: 10.1016/j.jiph.2015.05.003.
doi: 10.1016/j.jiph.2015.05.003 URL |
[14] |
Mekonnen D, Admassu A, Mulu W, et al. Multidrug-resistant and heteroresistant Mycobacterium tuberculosis and associated gene mutations in Ethiopia. Int J Infect Dis, 2015,39:34-38.doi: 10.1016/j.ijid.2015.06.013.
doi: 10.1016/j.ijid.2015.06.013 URL |
[15] |
杨建东, 陈阳贵, 马丽, 等. 乌鲁木齐市耐多药结核分枝杆菌基因突变特征分析. 中华疾病控制杂志, 2017,21(1):22-25.doi: 10.16462/j.cnki.zhjbkz.2017.01.005.
doi: 10.16462/j.cnki.zhjbkz.2017.01.005 |
[16] |
Zhang Y, Heym B, Young D, et al. The catalase-perox-idase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature, 1992,358(6387):591-593.
pmid: 1501713 |
[17] |
Nwofor AC, Nyamngee A, Nwabuisi C, et al. Performance of Genotype MTBDRplus in the Detection of Resistance to Rifampicin and Isoniazid Among Clinical Mycobacteria Isolates in Ilorin,Nigeria. Curr HIV Res, 2015,13(4):308-314. doi: 10.2174/1570162x13666150407143147.
doi: 10.2174/1570162x13666150407143147 URL |
[18] | 王先化. 新疆地区TB合并HIV感染流行病学分析及耐药结核分子机制研究. 青岛:青岛大学, 2015. |
[19] |
赛依旦·吐尔逊, 刘金宝, 阿尔泰, 等. 2013年新疆436例不同民族住院结核病患者的耐药情况分析. 中华疾病控制杂志, 2015,19(7):675-678. doi: 10.16462/j.cnki.zhjbkz.2015.07.008.
doi: 10.16462/j.cnki.zhjbkz.2015.07.008 |
[20] |
Zhao LL, Sun Q, Liu HC, et al. Analysis of embCAB mutations associated with ethambutol resistance in multidrug-resistant mycobacterium tuberculosis isolates from China. Antimicrob Agents Chemother, 2015,59(4):2045-2050. doi: 10.1128/AAC.04933-14.
doi: 10.1128/AAC.04933-14 URL |
[21] | Xu Y, Jia H, Huang H, et al. Mutations found in embCAB,em-bR,and ubiA genes of ethambutol-sensitive and -resistant myco-bacterium tuberculosis clinical isolates from China. Biomed Res Int, 2015,2015:951706. |
[22] |
杨亚滨, 博晓真, 高飞. 抗结核药物耐药分子机制的研究进展. 内蒙古医学杂志, 2015,47(2):195-198. doi: 10.16096/J.cnki.nmgyxzz.2015.47.02.023.
doi: 10.16096/J.cnki.nmgyxzz.2015.47.02.023 |
[23] |
Villellas C, Aristimuno L, Vitoria MA, et al. Analysis of mutations in streptomycin-resistant strains reveals a simple and reliable genetic marker for identification of the Mycobacterium tuberculosis Beijing genotype. J Clin Microbiol, 2013,51(7):2124-2130. doi: 10.1128/JCM.01944-12.
doi: 10.1128/JCM.01944-12 URL |
[24] | 陈高瞻, 芦莲, 雷航, 等. 结核分枝杆菌链霉素耐药临床分离株rrs基因突变与其耐药水平相关性研究. 武汉轻工大学学报, 2014,33(3):27-31. |
[25] |
Honore N, Marchal G, Cole ST, et al. Novel mutation in 16s rRNA associated with streptomycin dependence in Mycobacterium tuberculosis. Antimicrob Agents Chemother, 1995,39(3):769-770. doi: 10.1128/aac.39.3.769.
doi: 10.1128/aac.39.3.769 URL |
[1] | ZHANG Lei, LI Yuan-yuan, CHEN Xi, LIU Hai-ting, XU Jian, WANG Ning, DING Yang-ming, LU Yu. Study of the mechanism of the new antidrug-resistant tuberculosis drug pyrifazimine mediated by quinone oxidoreductase [J]. Chinese Journal of Antituberculosis, 2021, 43(6): 576-583. |
[2] | WU Tuo-ya, SHI Jin, GUO Ji-dong, LIU Yuan-yuan, PANG Yu, LU Jie, GAO Fei. Mechanism of miR-21-3p modulating the survival of Mycobacterium tuberculosis in host macrophage [J]. Chinese Journal of Antituberculosis, 2021, 43(5): 475-481. |
[3] | WANG Lu, XUE Zhong-tan, WANG Yu-feng, SHANG Yuan-yuan, REN Wei-cong, YAO Cong, GAO Fei, PANG Yu. A study of dynamic monitoring of drug sensitivity of Mycobacterium tuberculosis to bedaquiline and the mechanism of drug resistance [J]. Chinese Journal of Antituberculosis, 2021, 43(5): 482-486. |
[4] | LIU Min, LI Ming-jun, YU Qing, HE Kun, WU Yu-shan, YANG Hong-hong, LI Tong-xin. Bacteria distribution and drug resistance of co-infection patients of human immunodeficiency virus and nontuberculous mycobacteria in Chongqing [J]. Chinese Journal of Antituberculosis, 2021, 43(5): 501-505. |
[5] | LI Jun, ZHANG Qing-ling, ZHANG Yu, YANG Shang-peng, ZHAO Jian, ZHANG Yun. Analysis of drug resistance of first-line anti tuberculosis drugs in Jingzhou City of Hubei Province from 2015 to 2019 [J]. Chinese Journal of Antituberculosis, 2021, 43(5): 521-525. |
[6] | ZHANG Li-jie*, HAN Xi-qin, WANG Jing-ping, CHEN Yu-hui, CHEN Sheng-yu, CHEN Ling, LI Bo, LIN Ming-gui, LI You-lun, SHI Lian, XI Xiu-e, MA Li-ping, WANG Xin, WANG Fei, ZHAO Cai-yan, WANG Fu-rong, CHEN Sen-lin, WU Xiang, LI Po, ZHANG Peng, LENG Xue-yan, ZHANG Hai-qing, CAO Wen-li, SHU Wei, SUN Yu-xian, XIE Shi-heng, TIAN Xi-zhong, HUANG Xue-rui, DU Jian, GAO Wei-wei. The relationship between bacterial load and treatment failure and recurrence of sputum positive retreatment pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 335-340. |
[7] | LIANG Rui-yun, FANG Wei-jun, REN Hui-li, LI Hui-ru, ZHANG Hui, LI Cheng-cheng. Analysis of CT features of drug-resistant pulmonary tuberculosis with cavity [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 341-345. |
[8] | LIU Ting*, WANG Liang, YANG Mei. The study on the anti-tuberculosis activity of polymorphonuclear cell from peripheral blood of patients with multidrug-resistant pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 352-356. |
[9] | ZHANG Chen-chen*, TAN Wei-guo, GUO Hui-xin, HUANG Xin-chun, CHEN Yan-mei, WEI Wen-jing. The effect of Mycobacterium tuberculosis infection on sputum flora structure [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 357-363. |
[10] | BAI Hua, GUO Jing-wei, HU Pei-lei, YI Song-lin, WEN Jia, LIU Feng-ping, TAN Yun-hong, BAI Li-qiong. Analysis of drug resistance surveillance results of Mycobacterium tuberculosis in Hu’nan Province from 2014 to 2018 [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 364-369. |
[11] | HE Yi-jun, ZHANG Hao-ran, XIN He-nan, GAO Lei. Optimizing the application of tuberculin skin test [J]. Chinese Journal of Antituberculosis, 2021, 43(3): 204-210. |
[12] | WANG Xi-jiang, TAN Yun-hong, HE Wen-cong, OU Xi-chao, LIU Dong-xin, ZHAO Yan-lin. The correlation between rifampicin and isoniazid resistance-related gene mutations and resistance level in Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2021, 43(3): 248-254. |
[13] | DUAN Hui-juan, CHU Hong-qian, KONG Cheng-cheng, DAI Guang-ming, CAO Ting-ming, SUN Zhao-gang. Evaluation of the effect of skin reaction on 11 Mycobacterium tuberculosis antigens [J]. Chinese Journal of Antituberculosis, 2021, 43(3): 255-260. |
[14] | ZHANG Chun-xia, XU Gui-sheng, SHI Jin-yan. Research progress on diagnostic methods of multidrug-resistant tuberculosis [J]. Chinese Journal of Antituberculosis, 2021, 43(3): 291-294. |
[15] | KUANG Hao-bin, XIE Yu-hong, FENG Zhi-yu, QIN Hong-juan, LIAO Ya-yi, WANG Min, ZHANG Hong, YUANG Yuan, WU Di, CHEN Ze-ying, TAN Shou-yong. Analysis on the effect of management strategies for multidrug-resistant tuberculosis in Guangzhou from 2014-2019 [J]. Chinese Journal of Antituberculosis, 2021, 43(2): 113-118. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||